Krilogy Financial’s iShares iBonds Dec 2034 Term Corporate ETF IBDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.38M Buy
218,103
+16,176
+8% +$412K 0.15% 105
2026
Q2
$5.26M Sell
201,927
-2,141
-1% -$55.8K 0.16% 108
2026
Q1
$5.34M Buy
204,068
+4,673
+2% +$123K 0.17% 101
2025
Q4
$5.27M Buy
199,395
+3,375
+2% +$89.3K 0.18% 92
2025
Q3
$5.15M Buy
196,020
+16,040
+9% +$420K 0.19% 84
2025
Q2
$4.7M Sell
179,980
-25,388
-12% -$649K 0.27% 75
2025
Q1
$5.3M Buy
205,368
+27,027
+15% +$690K 0.34% 58
2024
Q4
$4.54M Buy
+178,341
New +$4.62M 0.3% 64

Other funds holding IBDZ

Krilogy Financial's IBDZ Position: Q3 2026 in Review

Krilogy Financial increased its iShares iBonds Dec 2034 Term Corporate ETF (IBDZ) stake by 8% in Q3 2026, buying an estimated $412K and bringing the position to 218,103 shares worth $5.38M. The position accounts for 0.15% of the portfolio, ranked #105.

Krilogy Financial first reported a position in IBDZ in Q4 2024 and has held it in 8 quarters since. 24 funds tracked by Wall St. Rank hold IBDZ as of Q3 2026.

  • Krilogy Financial held 218,103 shares of iShares iBonds Dec 2034 Term Corporate ETF worth $5.38M as of Q3 2026.
  • Krilogy Financial bought 16,176 iShares iBonds Dec 2034 Term Corporate ETF shares in Q3 2026, an estimated $412K.
  • iShares iBonds Dec 2034 Term Corporate ETF made up 0.15% of Krilogy Financial's portfolio in Q3 2026, its #105 holding.
  • Krilogy Financial first reported a position in iShares iBonds Dec 2034 Term Corporate ETF in Q4 2024 and has held it in 8 quarters since.
  • 24 funds tracked by Wall St. Rank held iShares iBonds Dec 2034 Term Corporate ETF as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.